
    
      An Open Label, Randomized, Two-Arm, Single-Dose, Two-Period, Crossover Study Relative
      Bioavailability Study. The present study is intended to compare and evaluate the relative
      bioavailability of a single 11 gram dose of AR10 (acetylcysteine effervescent tablets for
      oral solution (two 0.5 g and four 2.5 g]), and the reference Listed Drug (acetylcysteine
      solution; oral 20% [200 mg/mL] of American Pharmaceutical Partners) in healthy adult, human
      subjects under fasting conditions. A balanced block randomization schedule will be generated
      before the start of dosing.
    
  